Articles

  • Nov 29, 2024 | medium.com | Alexander Pan

    Alexander Pan·Follow6 min read·--Too many times I’ve seen outdated processes stand in the way between talented designers and good companies. The advance of technology was already fast. With AI joining the game, companies need talents to join to catch up. However, it’s not news that portfolios take weeks or even months to be in a job-ready state. When we think about a designer’s portfolio, it’s easy to imagine polished images and visually appealing user flows. And take-home design challenges?

  • Nov 21, 2024 | medium.com | Alexander Pan

    Alexander Pan·Follow4 min read·--In the past decade, the tech industry thrived, creating specialized roles like UX writers, user researchers, design ops specialists, and design system managers. These positions emerged as companies grew, and budgets allowed for niche expertise. However, a shift is underway.

  • Nov 16, 2024 | medium.com | Alexander Pan

    Alexander Pan·Follow3 min read·--In an era of endless notifications, looming deadlines, and an always-on work culture, productivity can feel elusive. The good news? Small, intentional changes can yield massive results. Let’s explore five proven methods to level up your productivity game and get more done without burning out. https://workbyilya.com/filter/design/Iron-Man-2-2010-Display-Graphics1.

  • Oct 5, 2024 | medium.com | Alexander Pan

    Alexander Pan·Follow5 min read·--Photo by Igor Omilaev on UnsplashThe future of human-computer interaction is shifting from screens and keyboards to immersive, wearable technologies. Devices like Meta’s Orion AR glasses and Apple’s Vision Pro are at the forefront of this transformation, leveraging AI to create new ways for people to engage with digital content and, crucially, each other.

  • Jan 20, 2024 | medrxiv.org | R. Taylor Sundby |Jeffrey Szymanski |Alexander Pan |Paul Jones

    R.T.S., J.J.S., A.A.C., A.C.H., A.P, and J.F.S. have patent filings related to cancer biomarkers. A.A.C has served as a consultant/advisor to Roche, Tempus, Geneoscopy, NuProbe, Daiichi Sankyo, AstraZeneca, Fenix Group International and Guidepoint. A.A.C. has served as a consultant/advisor to Roche, Tempus, Geneoscopy, Illumina, Myriad Genetics, Invitae, Daiichi Sankyo, AstraZeneca, NuProbe, AlphaSights, DeciBio, and Guidepoint. A.A.C. has received honoraria from Agilent, Roche, and Dava Oncology.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →